News | Computed Tomography (CT) | March 14, 2019

Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT

CT scanner brings personalized dose control and advanced cardiovascular capabilities to outpatient imaging settings

Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT

March 14, 2019 — Siemens Healthineers will introduce the Somatom go.Top Cardiovascular Edition, a new version of its established computed tomography (CT) system, at the 68th Annual Scientific Session and Expo of the American College of Cardiology (ACC), March 16-18 in New Orleans. The Somatom Go.Top Cardiovascular Edition is designed to deliver personalized patient dose control in all types of routine cardiovascular imaging. The cost-effective, 128-slice scanner offers outpatient cardiology offices as well as hospitals access to not just coronary CT angiography (CCTA), but also advanced tests, including the HeartFlow FFRCT (fractional flow reserve computed tomography) Analysis.

The system’s tablet-based mobile workflow not only simplifies and streamlines cardiac image acquisition, but it also enables the technologist to remain with the patient to help ensure comfort and calm – key factors for a successful cardiac exam. The CARE kV feature automatically selects the optimal kV setting for each patient with the precision of 10 kV increments, for personalized reduced radiation dose control as well as improved contrast enhancement. The system also has a fast native temporal resolution required for optimal visualization of coronary arteries.

The HeartFlow FFRCT Analysis, a personalized cardiac test developed by HeartFlow Inc., enables clinicians to better evaluate the impact a blockage has on blood flow and determine the best treatment for patients.

GO technologies help reduce workflow inconsistencies and variabilities that can result in poor image quality. For example, the Check&GO algorithm helps identify problems associated with anatomical coverage and contrast media distribution as they occur.

For more information: www.usa.healthcare.siemens.com

Related Content

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Overlay Init